To register for either the virtual webcast or the in-person event, please click here. CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic ...

CorMedix CRMD has been riding on the success of its lead product, DefenCath (taurolidine plus heparin), which was approved by the FDA in 2023 as the first and only antimicrobial catheter lock solution ...

Introduction: Reperfusion injury remains a major limitation in the management of ST-segment elevation myocardial infarction (STEMI). Despite numerous preclinical successes, cardioprotective strategies ...

Learn the critical factors in determining prophylaxis for venous thromboembolism, a frequent and serious complication for patients with cancer. Several factors play a role in deciding whether a ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

Pediatric Intensive Care Unit, The Affiliated Children’s Hospital of Xiangya School of Medicine, Central South University/Hunan Children’s Hospital, Changsha, China Objective: Optimal anticoagulation ...

This medication is used to keep IV catheters open and flowing freely. Heparin helps to keep blood flowing smoothly and from clotting in the catheter by making a certain natural substance in your body ...

BETHLEHEM, Pa., July 18, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections ...

A DVT diagnosis alongside cancer significantly increases health risks, necessitating immediate medical intervention to prevent potentially fatal complications like pulmonary embolism or stroke.